244 related articles for article (PubMed ID: 8668164)
21. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
[TBL] [Abstract][Full Text] [Related]
22. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.
Luo K; Lodish HF
EMBO J; 1997 Apr; 16(8):1970-81. PubMed ID: 9155023
[TBL] [Abstract][Full Text] [Related]
23. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
24. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
25. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
[TBL] [Abstract][Full Text] [Related]
26. Loss of receptors for transforming growth factor beta in human T-cell malignancies.
Kadin ME; Cavaille-Coll MW; Gertz R; Massagué J; Cheifetz S; George D
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6002-6. PubMed ID: 8016105
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M
Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253
[TBL] [Abstract][Full Text] [Related]
28. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
[TBL] [Abstract][Full Text] [Related]
29. Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.
Chen G; Ghosh P; Longo DL
Mol Cancer Res; 2011 Jan; 9(1):78-89. PubMed ID: 21131601
[TBL] [Abstract][Full Text] [Related]
30. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.
Cárcamo J; Zentella A; Massagué J
Mol Cell Biol; 1995 Mar; 15(3):1573-81. PubMed ID: 7862150
[TBL] [Abstract][Full Text] [Related]
31. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.
Turco A; Coppa A; Aloe S; Baccheschi G; Morrone S; Zupi G; Colletta G
Int J Cancer; 1999 Jan; 80(1):85-91. PubMed ID: 9935236
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
Feng XH; Filvaroff EH; Derynck R
J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
[TBL] [Abstract][Full Text] [Related]
35. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling.
Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399
[TBL] [Abstract][Full Text] [Related]
36. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
[TBL] [Abstract][Full Text] [Related]
37. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
[TBL] [Abstract][Full Text] [Related]
38. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
[TBL] [Abstract][Full Text] [Related]
39. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
40. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]